Science Explorer Back to mapMap
Hospital / health system · Nashville · United States

Tennessee Retina

In research, Tennessee Retina stands highest in Health Sciences (#7,745 of 16,688 worldwide) and Medicine (#9,237 of 14,558 worldwide), over all time. Relative to its size it is most specialised in Medicine and Health Sciences (Medicine is 4.3× its share of world research).

World rank, all time
#31,978
of 34,923
Rank in United States
#6,733
of 7,310
Research works
165
▼ 34% vs 2018-21
Citations
3.2k
19.6 per fractional work
Top-10% rate
8.6%
all institutions 10.0%
vs its own fields
0.99×
1.00× is exactly expected
Open access
30%
world 40%
International
23%
world 18%

What is Tennessee Retina known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #7,745 of 16,688 13.1%141
MedicineField #9,237 of 14,558 13.3%139

Each strip is that field's whole ranked pool, with the notch where Tennessee Retina sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Tennessee Retina work in?

In 2022-now, 84% of research at Tennessee Retina is in Health Sciences, 15% in Life Sciences. Its largest fields are Medicine (84%), Biochemistry, Genetics and Molecular Biology (10%), Immunology and Microbiology (3%). It does 2.8× the world's share of Health Sciences.

Health Sciences: 23 fractional works · 84.4% of its workMedicine: 23 fractional works · 83.6% of its workOphthalmology: 12 fractional works · 44.9% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 12.7% of its workEpidemiology: 1 fractional works · 4.9% of its workNeurology: 1 fractional works · 3.1% of its workPhysiology: 1 fractional works · 2.9% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.8% of its workOncology: 1 fractional works · 1.9% of its workRheumatology: 1 fractional works · 1.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.6% of its workSurgery: 0 fractional works · 1.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.7% of its workHematology: 0 fractional works · 0.7% of its workGenetics: 0 fractional works · 0.6% of its workOtorhinolaryngology: 0 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workNephrology: 0 fractional works · 0.4% of its workImmunology and Allergy: 0 fractional works · 0.3% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workInfectious Diseases: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.8% of its workEmergency Medical Services: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workLife Sciences: 4 fractional works · 14.6% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 9.7% of its workMolecular Biology: 1 fractional works · 3.9% of its workGenetics: 1 fractional works · 3.8% of its workBiophysics: 0 fractional works · 1.2% of its workCancer Research: 0 fractional works · 0.6% of its workCell Biology: 0 fractional works · 0.2% of its workImmunology and Microbiology: 1 fractional works · 3.3% of its workParasitology: 1 fractional works · 2.2% of its workImmunology: 0 fractional works · 0.8% of its workVirology: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.9% of its workToxicology: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.7% of its workCognitive Neuroscience: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 0 fractional works · 0.5% of its workEngineering: 0 fractional works · 0.5% of its workBiomedical Engineering: 0 fractional works · 0.5% of its workSocial Sciences: 0 fractional works · 0.4% of its workPsychology: 0 fractional works · 0.3% of its workSocial Psychology: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.1% of its workALL ITS WORKTennessee Retina27fractional works, 2022-now
Life Sciences15%Physical Sciences1%Health Sciences84%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 10 fields, with their numbers
    1. Medicine2383.6%
    2. Health Professions00.8%
    1. Biochemistry, Genetics and Molecular Biology39.7%
    2. Immunology and Microbiology13.3%
    3. Pharmacology, Toxicology and Pharmaceutics00.9%
    4. Neuroscience00.7%
    1. Engineering00.5%
    1. Psychology00.3%
    2. Social Sciences00.1%
    3. Decision Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Tennessee Retina specialise in?

Where its research is concentrated relative to its size: Medicine takes 4.3× the share of its output that it takes of world research.

  1. MedicineField · 22.9 works4.3×
  2. Health SciencesDomain · 23.1 works3.7×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.82× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 3.26× its world share, 1 worksImmunology and Micro…Neuroscience: 0.44× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.47× its world share, 0 worksPharmacology, Toxico…Engineering: 0.04× its world share, 0 worksEngineeringHealth Professions: 0.32× its world share, 0 worksHealth ProfessionsMedicine: 4.35× its world share, 23 worksMedicineDecision Sciences: 0.09× its world share, 0 worksDecision SciencesPsychology: 0.08× its world share, 0 worksPsychologySocial Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.3×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Medicine4.35×23 works
  2. Immunology and Microbiology3.26×1 works
  3. Pharmacology, Toxicology and Pharmaceutics2.47×0 works
  4. Biochemistry, Genetics and Molecular Biology1.82×3 works
  5. Neuroscience0.44×0 works
  6. Health Professions0.32×0 works
  7. Decision Sciences0.09×0 works
  8. Psychology0.08×0 works
  9. Engineering0.04×0 works
  10. Social Sciences0.01×0 works

Who are the top researchers at Tennessee Retina?

Ranked on the quality score, Carl C. Awh, BRANDON G. BUSBEE and Eric W. Schneider lead among researchers whose main affiliation is Tennessee Retina.

  1. 1 Carl C. Awh United States · #305,185 worldwide 4.1k citations · 66 works
  2. 2 BRANDON G. BUSBEE United States · #705,609 worldwide 3.3k citations · 71 works
  3. 3 Eric W. Schneider United States · #1,097,446 worldwide 978 citations · 43 works
  4. 4 David Alan Reichstein United States · #2,382,794 worldwide 672 citations · 56 works
  5. 5 Leff United States · #2,810,673 worldwide 24 citations · 121 works
  6. 6 Akshay S. Thomas United States · #4,001,596 worldwide 724 citations · 100 works
All ranked researchers at Tennessee Retina

What are the most cited papers from Tennessee Retina?

The most cited paper from Tennessee Retina is "Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study" (Peter A. Campochiaro, David M. Brown, Carl C. Awh et al., 2011), with 709 citations. Next come "Spectrum and Susceptibilities of Microbiologic Isolates in the Endophthalmitis Vitrectomy Study" (705) and "Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration" (590).

Most cited papers
#PaperReleasedCitations
1 Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study Peter A. Campochiaro, David M. Brown, Carl C. Awh et al. · Ophthalmology Jul 2011 709
2 Spectrum and Susceptibilities of Microbiologic Isolates in the Endophthalmitis Vitrectomy Study Dennis P. Han, Stephen R. Wisniewski, Louis A. Wilson et al. · American Journal of Ophthalmology Jul 1996 705
3 Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration Allen C. Ho, BRANDON G. BUSBEE, Carl D. Regillo et al. · Ophthalmology Open access 9 Jul 2014 590
4 Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration BRANDON G. BUSBEE, Allen C. Ho, David M. Brown et al. · Ophthalmology Open access 23 Jan 2013 506
5 Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration David S. Boyer, Andrew N. Antoszyk, Carl C. Awh et al. · Ophthalmology Feb 2007 398
All 60 most cited papers, with filters and sorting

Which keywords describe research at Tennessee Retina?

By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Intravitreal Injection, Macular Degeneration, Optical Coherence Tomography, Diabetic Retinopathy, Myopia, Behçet's Disease and Uveitis.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Epidemiology5▲ 4.9×11 topics
  2. Intravitreal Injection4▲ 197×2 topics
  3. Macular Degeneration4▲ 111×3 topics
  4. Optical Coherence Tomography4▲ 127×2 topics
  5. Diabetic Retinopathy3▲ 108×2 topics
  6. Inflammation3▲ 5.2×6 topics
  7. Myopia3▲ 157×2 topics
  8. Behçet's Disease3▲ 363×1 topic
  9. Uveitis3▲ 363×1 topic
  10. Glaucoma3▲ 66×3 topics
  11. Vascular Endothelial Growth Factor3▲ 112×2 topics
  12. Choroidal Thickness2▲ 165×1 topic
  13. Oxidative Stress2▲ 5.6×2 topics
  14. Retinal Pigment Epithelium2▲ 165×1 topic
  15. ACE2 Receptor2▲ 37×3 topics
  16. COVID-192▲ 6.3×2 topics
  17. OCT Imaging2▲ 264×2 topics
  18. Ocular Findings2▲ 296×1 topic
  19. Retinal Artery Occlusion2▲ 296×1 topic
  20. Macular Hole2▲ 316×1 topic
  21. Vitreoretinal Surgery2▲ 316×1 topic
  22. Genetic Mutations2▲ 16×4 topics
  23. Antibiotic Resistance2▲ 17×2 topics
  24. Optic Nerve2▲ 67×2 topics
  25. Risk Factors2▲ 5.2×4 topics
  26. Endophthalmitis2▲ 151×2 topics
  27. Keratitis2▲ 293×1 topic
  28. Ocular Infections2▲ 293×1 topic
  29. Intraocular Pressure1▲ 59×2 topics
  30. Ocular Hypertension1▲ 91×1 topic
  31. Retinal Ganglion Cells1▲ 43×1 topic

Which research topics does Tennessee Retina publish most on?

By volume in 2022-now: Ocular Diseases and Behçet’s Syndrome, Retinal Diseases and Treatments, Retinal and Optic Conditions and Retinal and Macular Surgery.

  1. 1 Ocular Diseases and Behçet’s Syndrome Ophthalmology 3 works
  2. 2 Retinal Diseases and Treatments Ophthalmology 2 works
  3. 3 Retinal and Optic Conditions Ophthalmology 2 works
  4. 4 Retinal and Macular Surgery Radiology, Nuclear Medicine and Imaging 2 works
  5. 5 Ocular Infections and Treatments Ophthalmology 2 works
  6. 6 Glaucoma and retinal disorders Ophthalmology 1 works
  7. 7 Ocular Disorders and Treatments Genetics 1 works
  8. 8 Ocular Oncology and Treatments Ophthalmology 1 works
  9. 9 Intraocular Surgery and Lenses Ophthalmology 1 works
  10. 10 Retinal Development and Disorders Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.0%not open70.0%

World: 40% of research is openly available.

with international co-authors22.9%domestic only77.1%

World: 18% is written across borders.

How has Tennessee Retina's research output changed?

Output in 2022-2025 was 34% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Tennessee Retina as a percentage of every work published that year, 0.000074% in 2024.

still counting0.00020%0.00040%0.00060%Tennessee Retina0.00013% in 20251990200020102020

Fractional works of Tennessee Retina over all fractional works that year. How the balance of science has shifted.

Other research institutions in Nashville

All research institutions in Nashville

Share Tennessee Retina's ranking

Tennessee Retina on Science Explorer

A card with Tennessee Retina's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Tennessee Retina. Posts are plain text and can be reported.